Canaccord Capital Corp Company Profile

01:35 EST 18th November 2017 | BioPortfolio

In 1968, the partners of Canaccord Capital acquired Hemsworth Turton & Co., a Western Canadian venture capital firm that opened its doors in 1950. Reborn as Canarim Investment Corporation, the small firm quickly became the principle financier of early stage ventures and the largest trader on the burgeoning Vancouver Stock Exchange. At that time, the core business was the early support and recognition of significant resource plays.In 1992, Canaccord Capital was incorporated and, by 1993, had 400 employees including 290 Investment Advisors located in six branches. That year, Canaccord implemented an aggressive growth strategy to evolve from a transaction-based business to an integrated financial services firm, meeting clients' diverse needs with a renewed commitment to quality.


P.O. Box 10337,Pacific Centre
Suite 2200
609 Granville Street
British Columbia
V7Y 1H2


Phone: (604) 684-5992

News Articles [506 Associated News Articles listed on BioPortfolio]

Zomedica Pharmaceuticals Corp. Announces US$5M Unsecured Working Capital Loan Facility

ANN ARBOR, Mich., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today ...

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will presen...

Akari Therapeutics PLC (AKTX) Receives Buy Rating from Canaccord Genuity

's stock had its "buy" rating restated by investment analysts at Canaccord Genuity in a research report issued to clients and investors on Friday. They currently have a $15.00 price objective on t...

Canaccord Genuity Analysts Give Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) a $522.00 Price Target

The firm presently has a "buy" rating on the biopharmaceutical company's stock. Canaccord Genuity's price objective suggests a potential upside of 2.61% from the stock's current price.

Apple-Aktie: installierte Basis wartet auf Jubiläums-iPhone! - Aktienanalyse

Vancouver - Apple-Aktienanalyse von Analyst T. Michael Walkley von Canaccord Genuity: Aktienanalyst T. Michael Walkley von Canaccord Genuity bestätigt im Rahmen einer Aktienanalyse seine Kaufempfeh.....

Microsoft-Aktie: Panikreaktionen sollten zur Prüfung genutzt werden! - Aktienanalyse

Vancouver - Microsoft-Aktienanalyse von Analyst Richard Davis von Canaccord Genuity: Laut einer Aktienanalyse empfiehlt Richard Davis, Aktienanalyst bei Canaccord Genuity, die Aktien des Software-H...

Advanced Micro Devices-Aktie: Ritterschlag von Intel! - Aktienanalyse

Vancouver - Advanced Micro Devices-Aktienanalyse des Analysten Matthew Ramsay von Canaccord Genuity: Im Rahmen einer Aktienanalyse empfiehlt Analyst Matthew Ramsay vom Investmenthaus Canaccord Genu...

CannaRoyalty CEO Marc Lustig to Present at Canaccord Genuity Growth Conference in Boston

OTTAWA, ONTARIO -- (Marketwired) -- 08/07/17 -- CannaRoyalty Corp. (CSE: CRZ)(CSE: CRZ.CN)(CNSX: CRZ)(OTCQX: CNNRF) ("CannaRoyalty" or the "Company"), a fully integrated, active investor and operato...

PubMed Articles [109 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

Recovery capital pathways: Modelling the components of recovery wellbeing.

In recent years, there has been recognition that recovery is a journey that involves the growth of recovery capital. Thus, recovery capital has become a commonly used term in addiction treatment and r...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

The effect of migration on social capital and depression among older adults in China.

An estimated 9 million elderly people accompanied their adult children to urban areas in China, raising concerns about their social capital and mental health following re-location. The aim of this stu...

Clinical Trials [34 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Social Inequalities in Emergency Call and Emergency Response Patterns

Background: Inequality in access to healthcare is a challenge internationally. Despite that medical emergency calls can be considered as access point to pre-hospital emergency care and ...

Treatment of Sub-Capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

The purpose of this study is to determine the performance and efficacy during 6 and 12 month post operation. 1. determine changes in patient pain level 2. determine changes in ...

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [1052 Associated Companies listed on BioPortfolio]

Canaccord Capital Corp

In 1968, the partners of Canaccord Capital acquired Hemsworth Turton & Co., a Western Canadian venture capital firm that opened its doors in 1950. Reborn as Canarim Investment Corporation, the small f...





Precision Engineered Products LLC

Irving Place Capital

Irving Place Capital invests private equity capital in buyouts, recapitalizations, and growth capital opportunities alongside superior management teams. Irving Place Capital focus...

More Information about "Canaccord Capital Corp" on BioPortfolio

We have published hundreds of Canaccord Capital Corp news stories on BioPortfolio along with dozens of Canaccord Capital Corp Clinical Trials and PubMed Articles about Canaccord Capital Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Canaccord Capital Corp Companies in our database. You can also find out about relevant Canaccord Capital Corp Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record